Home | GDATF

Show/Hide

San Diego Patient Event Postponed

March 10, 2020

After reviewing new guidelines from UCSD regarding COVID-19, we have made the decision to postpone our Graves'/TED seminar, which was previously scheduled for 4/11.

The UCSD guidelines, which are effective through May 10th, "strongly recommend" cancellation or postponement of events that bring groups of more than 15 people to campus. You can read the UCSD guidance in full here:

https://ucsdnews.ucsd.edu/covid-19?_ga=2.17876537.1425187151.1583822344-232675264.1583822344

Our intention is to reschedule this event as soon as it is deemed safe to do so.

***San Diego Patient Event Postponed***
March 10, 2020
After reviewing new guidelines from UCSD regarding COVID-19, we have made the decision to postpone our Graves'/TED seminar, which was previously scheduled for 4/11.

The UCSD guidelines, which are effective through May 10th, "strongly recommend" cancellation or postponement of events that bring groups of more than 15 people to campus. You can read the UCSD guidance in full here:

https://ucsdnews.ucsd.edu/covid-19?_ga=2.17876537.1425187151.1583822344-232675264.1583822344

Our intention is to reschedule this event as soon as it is deemed safe to do so.

Read More
Tepezza FDA Approval (teprotumumab-trbw)
Jan. 21, 2020
BREAKING NEWS: The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease. Wiley Chambers, M.D., deputy director of the Division of Transplant and Ophthalmology Products in the FDA’s Center for Drug Evaluation and Research noted, “Today’s approval marks an important milestone for the treatment of thyroid eye disease. Currently, there are very limited treatment options for this potentially debilitating disease. This treatment has the potential to alter the course of the disease, potentially sparing patients from needing multiple invasive surgeries by providing an alternative, non surgical treatment option.” Read more from the FDA regarding research results, adverse reactions, and the FDA's review process.

Read More
Neuropsychiatric Symptoms and Graves'
July 2, 2019
If you enjoyed the GDATF's patient bulletin "What's Wrong With Me? I'm Not Myself Anymore", then you won't want to miss the sequel! "A survey study of neuropsychiatric complaints in patients with Graves’ disease: A reassessment of self-reported symptoms and current practice 20 years later" is now available as an e-manuscript that is free with Kindle Unlimited or $2.99 with Amazon. Many thanks to Dr. James Arruda for conducting this ...

Read More
Recent News
- San Diego Patient Event!
  Feb. 7, 2020, 4:22 p.m.
- Tepezza (teprotumumab-trbw) Receives FDA Approval
  Jan. 21, 2020, 12:52 p.m.
- Teprotumumab Update
  Dec. 5, 2019, 9:14 a.m.
- Happy Holidays!
  Nov. 19, 2019, 4:26 p.m.
- Shop 'Til You Drop - And Help the GDATF!
  Nov. 8, 2019, 4:16 p.m.

Recent Forum Posts

Graves Disease and Radioactive Iodine Treatment

April 6, 2020, 5:49 p.m.

Hello - I remember when you were doing your senior project…time flies! Thanks so much for your support...
Insight please

April 6, 2020, 5:43 p.m.

Hello and welcome - We are fellow patients here and can't give medical advice…I wish I had more insight...
Graves Disease and Radioactive Iodine Treatment

April 4, 2020, 8:23 p.m.

Hello all! My name is Samantha Huneycutt and I am currently 21 years old and a college student at East...
Insight please

April 4, 2020, 3:46 a.m.

Hi, I’m new to the forum but happy I found. Graves’ disease can be lonely and depressing. I’m 35 with three...
(Update) CDC Webinar on COVID-19 and Autoimmunity

April 3, 2020, 7:27 p.m.

UPDATE: Although we did not get our Graves’-specific questions answered, the audio & slides from this...
(Update) CDC Webinar on COVID-19 and Autoimmunity

April 1, 2020, 3:36 p.m.

This looks like a FABULOUS program that will hopefully provide more detail on COVID-19 and autoimmunity than...
Synthroid to generic -what to expect?

March 27, 2020, 5:28 p.m.

Great news! That is crazy that a 90-day supply of Synthroid was that expensive. Wonder if it's one of those...
Synthroid to generic -what to expect?

March 24, 2020, 10:59 p.m.

Quick update. Switching from Synthroid to Generic was a breeze. I guess I got caught up in the hype. Happy...
Day 3 Newly diagnosed checking in

March 16, 2020, 5:55 p.m.

Hello and welcome - make sure that you are looking at the “normal” or “reference”...
Day 3 Newly diagnosed checking in

March 15, 2020, 12:38 a.m.

Hello all, I have been newly diagnosed with Graves this past Friday after dealing with some ridiculous...
***San Diego Patient Event Postponed***

March 10, 2020, 6:34 p.m.

After reviewing new guidelines from UCSD regarding COVID-19, we have made the decision to postpone our...
Opinions

March 3, 2020, 7:29 a.m.

Hello - We are fellow patients and can't interpret labs or give medical advice, *but* I would follow up with...
Opinions

Feb. 28, 2020, 9:51 p.m.

Hello, I would like your opinions again about my results and if after treatment the psychological issues...
Methimazole side effect - terrible joint pain

Feb. 27, 2020, 3:43 p.m.

@jstewart084 - Hello and welcome! This is a challenging issue. Getting levels checked would be a good start....
Methimazole side effect - terrible joint pain

Feb. 22, 2020, 10:59 a.m.

Hello, I had this same question about working with Graves' Disease. It would be helpful if more people could...

***San Diego Patient Event Postponed***

***San Diego Patient Event Postponed***

Tepezza FDA Approval (teprotumumab-trbw)

Neuropsychiatric Symptoms and Graves'

Recent News

Recent Forum Posts

Questions? Problems? Please contact us at [email protected] or 877-643-3123.

San Diego Patient Event Postponed

San Diego Patient Event Postponed